Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates |
| |
Authors: | Geisbert Thomas W Daddario-DiCaprio Kathleen M Williams Kinola J N Geisbert Joan B Leung Anders Feldmann Friederike Hensley Lisa E Feldmann Heinz Jones Steven M |
| |
Institution: | National Emerging Infectious Diseases Laboratories Institute, Boston, Massachusetts, USA. geisbert@bu.edu |
| |
Abstract: | Recombinant vesicular stomatitis virus (VSV) vectors expressing homologous filoviral glycoproteins can completely protect rhesus monkeys against Marburg virus when administered after exposure and can partially protect macaques after challenge with Zaire ebolavirus. Here, we administered a VSV vector expressing the Sudan ebolavirus (SEBOV) glycoprotein to four rhesus macaques shortly after exposure to SEBOV. All four animals survived SEBOV challenge, while a control animal that received a nonspecific vector developed fulminant SEBOV hemorrhagic fever and succumbed. This is the first demonstration of complete postexposure protection against an Ebola virus in nonhuman primates and provides further evidence that postexposure vaccination may have utility in treating exposures to filoviruses. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |